Citation Impact
Citing Papers
Interactions of Abiraterone, Eplerenone, and Prednisolone with Wild-type and Mutant Androgen Receptor: A Rationale for Increasing Abiraterone Exposure or Combining with MDV3100
2012
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Abrogation of De novo Lipogenesis by Stearoyl-CoA Desaturase 1 Inhibition Interferes with Oncogenic Signaling and Blocks Prostate Cancer Progression in Mice
2010
The Isopeptidase USP2a Protects Human Prostate Cancer from Apoptosis
2006
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
2009 StandoutScience
HIF-1-Mediated Suppression of Acyl-CoA Dehydrogenases and Fatty Acid Oxidation Is Critical for Cancer Progression
2014 StandoutNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
mTOR Signaling in Growth Control and Disease
2012 Standout
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
2012 Standout
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
2012 Standout
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
2007 Standout
Bicalutamide (Casodex®) in the treatment of prostate cancer
2004
Androgens, lipogenesis and prostate cancer
2004
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Cancer Cell Metabolism: Warburg and Beyond
2008 Standout
New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
2010 Standout
The androgen receptor gene and its influence on the development and progression of prostate cancer
2001
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Prostate cancer
2015
Smad4 Inhibits Tumor Growth by Inducing Apoptosis in Estrogen Receptor-α-positive Breast Cancer Cells
2005
Increased lipogenesis in cancer cells: new players, novel targets
2006
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
2006
A Genomic and Functional Inventory of Deubiquitinating Enzymes
2005 Standout
Hormone Status Selects for Spontaneous Somatic Androgen Receptor Variants That Demonstrate Specific Ligand and Cofactor Dependent Activities in Autochthonous Prostate Cancer
2001
The development of androgen-independent prostate cancer
2001 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Hypoxia signaling pathways in cancer metabolism: the importance of co-selecting interconnected physiological pathways
2014 StandoutNobel
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Validity of four pain intensity rating scales
2011 Standout
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines
2008
Regulation of Ferroptotic Cancer Cell Death by GPX4
2014 Standout
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma☆
2006
Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)
2001
Breaking the chains: structure and function of the deubiquitinases
2009 Standout
Androgen Receptor Signaling in Androgen-Refractory Prostate Cancer
2001
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component
2005
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
2004
Dynamic aberrant NF-κB spurs tumorigenesis: A new model encompassing the microenvironment
2015
Multi-targeted therapy of cancer by genistein
2008 Standout
Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance
2004
Cellular Fatty Acid Metabolism and Cancer
2013 Standout
4-(Anilino)pyrrole-2-carboxamides: Novel non-steroidal/non-anilide type androgen antagonists effective upon human prostate tumor LNCaP cells with mutated nuclear androgen receptor
2008
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
2018
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Androgen receptor as a target in androgen-independent prostate cancer
2002
The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer
2004
Androgen receptors and their biology
2001
ROS and the DNA damage response in cancer
2018 Standout
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
2015 Standout
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
2004
The Crystal Structure of Yeast Fatty Acid Synthase, a Cellular Machine with Eight Active Sites Working Together
2007 StandoutNobel
Bicalutamide Functions as an Androgen Receptor Antagonist by Assembly of a Transcriptionally Inactive Receptor
2002
Prostate cancer invasion and metastasis: insights from mining genomic data
2013
HIGH DOSE BICALUTAMIDE FOR ANDROGEN INDEPENDENT PROSTATE CANCER: EFFECT OF PRIOR HORMONAL THERAPY
1998
Fatty acid synthase: A metabolic oncogene in prostate cancer?
2003
Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist.
1999
Complex disease, gender and epigenetics
2006
Clues from cell metabolism
2010 StandoutNatureNobel
Practical, Catalytic, Asymmetric Synthesis of β-Lactones via a Sequential Ketene Dimerization/Hydrogenation Process: Inhibitors of the Thioesterase Domain of Fatty Acid Synthase
2006
Coactivator SRC-2–dependent metabolic reprogramming mediates prostate cancer survival and metastasis
2015
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Natural Polyphenols for Prevention and Treatment of Cancer
2016 Standout
Increased Expression of Genes Converting Adrenal Androgens to Testosterone in Androgen-Independent Prostate Cancer
2006 Standout
Ligand responsiveness in human prostate cancer: structural analysis of mutant androgen receptors from LNCaP and CWR22 tumors.
2000
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Aerobic Glycolysis: Meeting the Metabolic Requirements of Cell Proliferation
2011 Standout
Plk1 Inhibition Enhances the Efficacy of Androgen Signaling Blockade in Castration-Resistant Prostate Cancer
2014
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Activation of AMPK by Pterostilbene Suppresses Lipogenesis and Cell-Cycle Progression in p53 Positive and Negative Human Prostate Cancer Cells
2012
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer
2005 Standout
Phosphine Organocatalysis
2018 Standout
Antiandrogen Bicalutamide Promotes Tumor Growth in a Novel Androgen-Dependent Prostate Cancer Xenograft Model Derived from a Bicalutamide-Treated Patient
2005
Mechanism of Apoptosis Induced by the Inhibition of Fatty Acid Synthase in Breast Cancer Cells
2006
Tumor localization of 16beta-18F-fluoro-5alpha-dihydrotestosterone versus 18F-FDG in patients with progressive, metastatic prostate cancer.
2004
Inhibition of Fatty Acid Synthase Induces Endoplasmic Reticulum Stress in Tumor Cells
2007
Targeting Fatty Acid Synthase in Breast and Endometrial Cancer: An Alternative to Selective Estrogen Receptor Modulators?
2006
Collocation of androgen receptor gene mutations in prostate cancer.
2001
TALEN-engineered AR gene rearrangements reveal endocrine uncoupling of androgen receptor in prostate cancer
2013
Fatty Acid Synthase As a Potential Therapeutic Target in Cancer
2010
Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Bioorthogonal Labeling of Human Prostate Cancer Tissue Slice Cultures for Glycoproteomics
2017 StandoutNobel
Roles of NF-κB in Cancer and Inflammatory Diseases and Their Therapeutic Approaches
2016 Standout
Androgen Receptor Mutations in Androgen-Independent Prostate Cancer: Cancer and Leukemia Group B Study 9663
2003
Novel antagonists of the thioesterase domain of human fatty acid synthase
2007
Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling Axis
2005
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
2012 Standout
Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
2008 Standout
Androgen Receptor in Prostate Cancer
2004
Works of Stephen Balk being referenced
Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
2011
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer.
2003
Targeting Steroid Hormone Receptor Pathways in the Treatment of Hormone Dependent Cancers
2004
Functional characterization of mutant androgen receptors from androgen-independent prostate cancer.
1997